Showing 2131-2140 of 8831 results for "".
ePrime
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/eprime/19381/Overview of the ePrime system for reduction in wrinkles and increase in foundational skin volume. The system uses precisely controlled radiofrequency delivery for energy-based dermal remodeling. Aspects of the system, its benefits, and impact on the practice are reviewed.Tattoo Removal
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/tattoo-removal--ponideho/19401/Dr. Amy Derick addresses tattoo removal through the latest laser technology.Dr. Garden Discusses Experience with the VariLite Laser
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dr-garden-discusses-experience-with-gemini-laser/19467/"The VariLite system is a wonderful choice for those people who want to enter into the laser arena. Because many, many patients have vessels which naturally occur as they grow older or especially those who develop rosacea later in life, this is something that many practices have the need for treatSpecial Report: COVID-19: Surgeons Support Front Lines, How to Cope
https://practicaldermatology.com/topics/practice-management/special-report-covid-19-surgeons-support-front-lines-how-to-cope/19757/The AAFPRS calls on surgeons to consider donating PPE and supplies like ventilators and beds, as nurses call for more preparation for COVID-19. Experts offer strategies for coping with the current environment and planning ahead. Although the AAD Annual Meeting has been cancelled, voting for new offiExploring the Benefits of Nitric Oxide for Hair Loss Patients Through REVIAN® Red
https://practicaldermatology.com/topics/hair-nails/exploring-the-benefits-of-nitric-oxide-for-hair-loss-patients-through-revian-red/19753/Learn more about the mechanism of action of the new REVIAN Red Dual-Band LED light therapy cap and what makes it unique from other at-home FDA-cleared devices. REVIAN Red is indicated to treat androgenetic alopecia and to promote hair growth in males who have Norwood-Hamilton classifications of IIaVitiligo: Current and Future Developments
https://practicaldermatology.com/conferences/maui-derm-2020/vitiligo-current-and-future-developments/19722/John E. Harris, MD, PhD reviews treatment advances and emerging science in vitiligo. From new topical agents to intriguing studies on a potential role for biologics, there is very good reason to be optimistic about the future of vitiligo treatment.Journal Club: Blocking IL-4/IL-13 vs JAK/STAT
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-blocking-il-4il-13-vs-jakstat/29101/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, speaks with Editorial Board member Peter Lio, MD, about the Journal of Personalized Medicine article, "Blocking the IL-4/IL-13 Axis versus the JAK/STAT Pathway in Atopic Dermatitis: How Can We Choose?"Science of Skincare Summit 2024: Grab-Bag- Current Topics in Derm
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-grab-bag-current-topics-in-derm/29453/Jennifer Soung, MD, an assistant professor of dermatology at Baylor College of Medicine, and Raja Sivamani, MD, MS, a dermatologist at University of California Davis, join Drs. Todd Schlesinger, James Del Rosso, DO, and Neal Bhatia, MD, for a short discussion about a number of current topics in dermThe First 5 Minutes with a Patient
https://practicaldermatology.com/series/pa-perspectives/first-5-minutes-patient/27105/In this video, Andrew Mastro, MS, PA-C, a board-certified physician assistant (PA) at the Illinois Dermatology Institute in Chicago, discusses the importance of crafting the right message during the first 5 minutes with a patient.Treating Non-melanoma Skin Cancer: What’s New and Exciting
https://practicaldermatology.com/conferences/scale-2023/treating-non-melanoma-skin-cancer-whats-new-and-exciting/20201/Dermatologists have a host of new tools for treating advanced basal and squamous cell carcinomas. Todd Schlesinger, MD, discusses hedgehog pathway inhibitors and immunotherapy and their growing role in treating non-melanoma skin cancers.